| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $183.2M | — | +9.7% |
| Cost of Revenue | $44.0M | — | +7.5% |
| Gross Profit | $139.2M | — | +10.4% |
| R&D Expense | $30.6M | — | +18.8% |
| SG&A Expense | $33.2M | — | +17.3% |
| Operating Income | $6.2M | — | +74.4% |
| Pre-tax Income | $9.8M | — | -1.5% |
| Income Tax | $5.9M | — | +26.5% |
| Net Income | $8.1M | — | +34.2% |
| EPS (Basic) | $0.14 | — | +40.0% |
| EPS (Diluted) | $0.13 | — | +30.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $242.0M | -37.9% | -49.5% |
| Accounts Receivable | $174.9M | -19.8% | +19.3% |
| Current Assets | $732.1M | -28.6% | -29.8% |
| Total Assets | $1.46B | -17.3% | -18.3% |
| Current Liabilities | $429.7M | -38.2% | -31.8% |
| Total Liabilities | $1.12B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $46.3M | — | -1.0% |
| Capital Expenditures | $2.1M | — | -64.4% |
| Investing Cash Flow | $96.9M | — | +124.3% |
| Financing Cash Flow | -$291.0M | — | -435.9% |
| Free Cash Flow | $44.2M | — | +8.3% |
| -15.8% |
| Stockholders' Equity | $305.9M | -7.9% | -26.8% |